Jeng MH - Search Results

1

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

Lu M, Miller KD, Gokmen-Polar Y, Jeng MH, Kinch MS. Lu M, et al. Among authors: jeng mh. Cancer Res. 2003 Jun 15;63(12):3425-9. Cancer Res. 2003. PMID: 12810680

2

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.

Jung C, Kim RS, Lee SJ, Wang C, Jeng MH. Jung C, et al. Among authors: jeng mh. Cancer Res. 2004 May 1;64(9):3046-51. doi: 10.1158/0008-5472.can-03-2614. Cancer Res. 2004. PMID: 15126340

3

HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.

Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. Jung C, et al. Among authors: jeng mh. Cancer Res. 2004 Dec 15;64(24):9185-92. doi: 10.1158/0008-5472.CAN-04-1330. Cancer Res. 2004. PMID: 15604291

4

Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy.

Li X, Liu YH, Zhang YP, Zhang S, Pu X, Gardner TA, Jeng MH, Kao C. Li X, et al. Among authors: jeng mh. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5463-73. doi: 10.1158/1078-0432.CCR-07-0342. Clin Cancer Res. 2007. PMID: 17875776

5

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.

Hong H, Kao C, Jeng MH, Eble JN, Koch MO, Gardner TA, Zhang S, Li L, Pan CX, Hu Z, MacLennan GT, Cheng L. Hong H, et al. Among authors: jeng mh. Cancer. 2004 Jul 1;101(1):83-9. doi: 10.1002/cncr.20327. Cancer. 2004. PMID: 15221992 Free article.

6

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.

Li X, Zhang YP, Kim HS, Bae KH, Stantz KM, Lee SJ, Jung C, Jiménez JA, Gardner TA, Jeng MH, Kao C. Li X, et al. Among authors: jeng mh. Cancer Res. 2005 Mar 1;65(5):1941-51. doi: 10.1158/0008-5472.CAN-04-3666. Cancer Res. 2005. PMID: 15753394

7

Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.

Matei D, Chang DD, Jeng MH. Matei D, et al. Among authors: jeng mh. Clin Cancer Res. 2004 Jan 15;10(2):681-90. doi: 10.1158/1078-0432.ccr-0754-03. Clin Cancer Res. 2004. PMID: 14760091

8

PDGF BB induces VEGF secretion in ovarian cancer.

Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW. Matei D, et al. Among authors: jeng mh. Cancer Biol Ther. 2007 Dec;6(12):1951-9. doi: 10.4161/cbt.6.12.4976. Epub 2007 Sep 1. Cancer Biol Ther. 2007. PMID: 18075302 Free article.

9

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter.

Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH. Li X, et al. Among authors: jeng mh. Mol Cancer Ther. 2005 Dec;4(12):1850-9. doi: 10.1158/1535-7163.MCT-05-0167. Mol Cancer Ther. 2005. PMID: 16373700

10

Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.

Li X, Liu YH, Lee SJ, Gardner TA, Jeng MH, Kao C. Li X, et al. Among authors: jeng mh. Clin Cancer Res. 2008 Jan 1;14(1):291-9. doi: 10.1158/1078-0432.CCR-07-0867. Clin Cancer Res. 2008. PMID: 18172281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters